{"id":2031,"date":"2022-01-26T14:53:55","date_gmt":"2022-01-26T13:53:55","guid":{"rendered":"http:\/\/invivo.partners\/2022\/01\/26\/retina-difficult-indications\/"},"modified":"2025-10-28T18:03:52","modified_gmt":"2025-10-28T17:03:52","slug":"retina-difficult-indications","status":"publish","type":"post","link":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/","title":{"rendered":"RETINA (INDICACIONS DIF\u00cdCILS):"},"content":{"rendered":"

Les malalties de la retina continuen essent un problema dif\u00edcil de resoldre perqu\u00e8:
\n(1) la retina \u00e9s, en certa manera, un ordinador biol\u00f2gic que cal \u201creconnectar\u201d correctament;
\n(2) els models animals s\u00f3n poc fiables, ja que no tenen f\u00f2vea;
\n(3) la membrana limitant interna (ILM) en limita l\u2019administraci\u00f3 de tractaments, i
\n(4) la regeneraci\u00f3 de la retina en mam\u00edfers \u00e9s inexistent.<\/p>\n

Tanmateix, estan sorgint estrat\u00e8gies molt prometedores. A continuaci\u00f3 es mostra un mapa conceptual de les aproximacions m\u00e9s interessants per resoldre aquest problema<\/p>\n

#quick_notes_lp<\/strong><\/a><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Les malalties de la retina continuen essent un problema dif\u00edcil de resoldre perqu\u00e8: (1) la retina \u00e9s, en certa manera, un ordinador biol\u00f2gic que cal \u201creconnectar\u201d correctament; (2) els models animals s\u00f3n poc fiables, ja que no tenen f\u00f2vea; (3) la membrana limitant interna (ILM) en limita l\u2019administraci\u00f3 de tractaments, i (4) la regeneraci\u00f3 de<\/p>\n","protected":false},"author":1,"featured_media":2028,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[585],"tags":[],"class_list":["post-2031","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ideas-lab-2"],"acf":[],"yoast_head":"\nRETINA (INDICACIONS DIF\u00cdCILS): - Invivo Partners<\/title>\n<meta name=\"description\" content=\"Retinal diseases remain a difficult problem to solve because (1) the retina is in a sense a biological computer that needs to be properly "rewired", (2) animal models are poor because they have no fovea, (3) the internal limiting membrane (ILM) limits delivery, and (4) regeneration of mammalian retinal is absent. However, very promising strategies are emerging, here is a conceptual map of the most interesting approaches to solve the problem. #quick_notes_lp\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RETINA (INDICACIONS DIF\u00cdCILS): - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Retinal diseases remain a difficult problem to solve because (1) the retina is in a sense a biological computer that needs to be properly "rewired", (2) animal models are poor because they have no fovea, (3) the internal limiting membrane (ILM) limits delivery, and (4) regeneration of mammalian retinal is absent. However, very promising strategies are emerging, here is a conceptual map of the most interesting approaches to solve the problem. #quick_notes_lp\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-26T13:53:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T17:03:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/invivo.partners\/wp-content\/uploads\/2022\/01\/RETINA.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"829\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"invivo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"invivo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/\"},\"author\":{\"name\":\"invivo\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\"},\"headline\":\"RETINA (INDICACIONS DIF\u00cdCILS):\",\"datePublished\":\"2022-01-26T13:53:55+00:00\",\"dateModified\":\"2025-10-28T17:03:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/\"},\"wordCount\":94,\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"articleSection\":[\"Ideas Lab\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/\",\"url\":\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/\",\"name\":\"RETINA (INDICACIONS DIF\u00cdCILS): - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2022-01-26T13:53:55+00:00\",\"dateModified\":\"2025-10-28T17:03:52+00:00\",\"description\":\"Retinal diseases remain a difficult problem to solve because (1) the retina is in a sense a biological computer that needs to be properly \\\"rewired\\\", (2) animal models are poor because they have no fovea, (3) the internal limiting membrane (ILM) limits delivery, and (4) regeneration of mammalian retinal is absent. However, very promising strategies are emerging, here is a conceptual map of the most interesting approaches to solve the problem. #quick_notes_lp\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RETINA (INDICACIONS DIF\u00cdCILS):\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\",\"name\":\"invivo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"caption\":\"invivo\"},\"url\":\"https:\/\/invivo.partners\/ca\/author\/invivocapital\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RETINA (INDICACIONS DIF\u00cdCILS): - Invivo Partners","description":"Retinal diseases remain a difficult problem to solve because (1) the retina is in a sense a biological computer that needs to be properly \"rewired\", (2) animal models are poor because they have no fovea, (3) the internal limiting membrane (ILM) limits delivery, and (4) regeneration of mammalian retinal is absent. However, very promising strategies are emerging, here is a conceptual map of the most interesting approaches to solve the problem. #quick_notes_lp","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/","og_locale":"ca_ES","og_type":"article","og_title":"RETINA (INDICACIONS DIF\u00cdCILS): - Invivo Partners","og_description":"Retinal diseases remain a difficult problem to solve because (1) the retina is in a sense a biological computer that needs to be properly \"rewired\", (2) animal models are poor because they have no fovea, (3) the internal limiting membrane (ILM) limits delivery, and (4) regeneration of mammalian retinal is absent. However, very promising strategies are emerging, here is a conceptual map of the most interesting approaches to solve the problem. #quick_notes_lp","og_url":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/","og_site_name":"Invivo Partners","article_published_time":"2022-01-26T13:53:55+00:00","article_modified_time":"2025-10-28T17:03:52+00:00","og_image":[{"width":800,"height":829,"url":"https:\/\/invivo.partners\/wp-content\/uploads\/2022\/01\/RETINA.jpg","type":"image\/jpeg"}],"author":"invivo","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"invivo","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/#article","isPartOf":{"@id":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/"},"author":{"name":"invivo","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789"},"headline":"RETINA (INDICACIONS DIF\u00cdCILS):","datePublished":"2022-01-26T13:53:55+00:00","dateModified":"2025-10-28T17:03:52+00:00","mainEntityOfPage":{"@id":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/"},"wordCount":94,"publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"articleSection":["Ideas Lab"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/","url":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/","name":"RETINA (INDICACIONS DIF\u00cdCILS): - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2022-01-26T13:53:55+00:00","dateModified":"2025-10-28T17:03:52+00:00","description":"Retinal diseases remain a difficult problem to solve because (1) the retina is in a sense a biological computer that needs to be properly \"rewired\", (2) animal models are poor because they have no fovea, (3) the internal limiting membrane (ILM) limits delivery, and (4) regeneration of mammalian retinal is absent. However, very promising strategies are emerging, here is a conceptual map of the most interesting approaches to solve the problem. #quick_notes_lp","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/2022\/01\/26\/retina-difficult-indications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"RETINA (INDICACIONS DIF\u00cdCILS):"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789","name":"invivo","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","caption":"invivo"},"url":"https:\/\/invivo.partners\/ca\/author\/invivocapital\/"}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/2031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/comments?post=2031"}],"version-history":[{"count":2,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/2031\/revisions"}],"predecessor-version":[{"id":3927,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/2031\/revisions\/3927"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media\/2028"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=2031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/categories?post=2031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/tags?post=2031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}